SCHEMBL101634

SCHEMBL101634

COc1cc(NC(=O)CCCc2ccc(-c3ccccc3)c(NC(=O)O)c2)c(Cl)cc1CO

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
POLB P06746 3/20 0.46
HPGD P15428 2/20 0.46
CHEK1 O14757 1/20 0.45
RAB9A P51151 4/20 0.45
NPC1 O15118 3/20 0.45
TRPV1 Q8NER1 2/20 0.43
SMN1; SMN2 Q16637 2/20 0.42
LTB4R Q15722 1/20 0.42
PDCD1 Q15116 1/20 0.42
CD274 Q9NZQ7 1/20 0.42
KMT2A Q03164 2/20 0.41
MEN1 O00255 1/20 0.41
ALDH1A1 P00352 3/20 0.41
LMNA P02545 2/20 0.41
HTT P42858 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
KDM4E B2RXH2 1/20 0.40
NPSR1 Q6W5P4 1/20 0.40
MAPT P10636 1/20 0.40
MAPK10 P53779 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL100422 0.94 HPGD (0.51) POLBHPGDCHEK1RAB9ANPC1
SCHEMBL99878 0.91 KDM4E (0.43) POLBHPGDCHEK1RAB9ANPC1
SCHEMBL100933 0.89 POLB (0.46) POLBHPGDRAB9ANPC1TRPV1
SCHEMBL15823257 0.88 POLB (0.45) POLBHPGDCHEK1RAB9ANPC1
SCHEMBL15824060 0.88 ALDH1A1 (0.42) POLBHPGDRAB9ANPC1SMN1; SMN2
SCHEMBL97653 0.87 CHEK1 (0.42) POLBHPGDCHEK1RAB9ANPC1
SCHEMBL99703 0.86 NPC1 (0.58) POLBHPGDRAB9ANPC1TRPV1
SCHEMBL660876 0.84 CHRM3 (0.50)
SCHEMBL98803 0.84 POLB (0.50) POLBHPGDRAB9ANPC1TRPV1
Iodide SCHEMBL661743 0.84 CHRM3 (0.44) POLBHPGDCHEK1RAB9ANPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2426121-A1 QUATERNARY AMMONIUM SALT COMPOUND Teijin Pharma Limited (JP) 2012-03-07 EP claimed
EP-2934594-B1 CYCLOHEXYL AND QUINUCLIDINYL CARBAMATE DERIVATIVES HAVING BETA2 ADRENERGIC AGONIST AND M3 MUSCARINIC ANTAGONIST ACTIVITIES . ALMIRALL SA (ES) 2019-09-04 EP disclosed
EP-2934594-A1 NEW CYCLOHEXYL AND QUINUCLIDINYL CARBAMATE DERIVATIVES HAVING BETA2 ADRENERGIC AGONIST AND M3 MUSCARINIC ANTAGONIST ACTIVITY Almirall, S.A. (ES) 2015-10-28 EP disclosed
WO-2014095920-A1 NEW CYCLOHEXYL AND QUINUCLIDINYL CARBAMATE DERIVATIVES HAVING BETA2 ADRENERGIC AGONIST AND M3 MUSCARINIC ANTAGONIST ACTIVITY ALMIRALL, S.A. (ES) 2014-06-26 WO disclosed